Amgen Inc.
GB ˙ BATS-CHIXE ˙ NL0000888691
SecurityGB:AMGD / Amgen Inc.
InstitutionBeacon Pointe Advisors, LLC
Latest Disclosed Ownership114,444 shares
Latest Disclosed Value $ 40,267,279
Beacon Pointe Advisors, LLC reports 44.19% increase in ownership of AMGD / Amgen Inc.

On May 15, 2026 - Beacon Pointe Advisors, LLC filed a 13F-HR form disclosing ownership of 114,444 shares of Amgen Inc. (GB:AMGD) valued at $40,267,279 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 18, 2026 disclosing 79,370 shares of Amgen Inc.. This represents a change in shares of 44.19% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AMGEN COM 031162100 114,444 35,074 44.19 40,267 55.00 0.2129
2026-02-18 2025-12-31 13F AMGEN COM 031162100 79,370 767 0.98 25,979 17.12 0.1821
2025-11-14 2025-09-30 13F AMGEN COM 031162100 78,603 -9,378 -10.66 22,182 -9.70 0.1879
2025-08-13 2025-06-30 13F AMGEN COM 031162100 87,981 -4,768 -5.14 24,565 -14.99 0.2564
2025-05-13 2025-03-31 13F AMGEN COM 031162100 92,749 547 0.59 28,896 20.24 0.3245
2025-02-14 2024-12-31 13F AMGEN COM 031162100 92,202 -33,386 -26.58 24,032 -40.61 0.2663
2024-11-14 2024-09-30 13F AMGEN COM 031162100 125,588 5,910 4.94 40,466 8.22 0.4665
2024-08-12 2024-06-30 13F AMGEN COM 031162100 119,678 7,340 6.53 37,393 17.08 0.4422
2024-05-14 2024-03-31 13F AMGEN COM 031162100 112,338 -4,075 -3.50 31,940 -4.74 0.3552
2024-02-08 2023-12-31 13F AMGEN COM 031162100 116,413 1,312 1.14 33,529 8.39 0.4007
2023-11-14 2023-09-30 13F AMGEN COM 031162100 115,101 21,535 23.02 30,934 48.91 0.3855
2023-08-14 2023-06-30 13F AMGEN COM 031162100 93,566 -16,335 -14.86 20,774 -21.81 0.3393
2023-05-12 2023-03-31 13F AMGEN COM 031162100 109,901 -4,187 -3.67 26,569 -11.33 0.4529
2023-02-14 2022-12-31 13F AMGEN COM 031162100 114,088 7,099 6.64 29,964 24.23 0.5812
2022-11-09 2022-09-30 13F AMGEN COM 031162100 106,989 22 0.02 24,120 -7.27 0.5397
2022-08-11 2022-06-30 13F AMGEN COM 031162100 106,967 -19,740 -15.58 26,010 -15.11 0.5490
2022-05-17 2022-03-31 13F AMGEN COM 031162100 126,707 45,284 55.62 30,640 67.28 0.4200
2022-02-14 2021-12-31 13F AMGEN COM 031162100 81,423 -17,943 -18.06 18,317 -13.31 0.4773
2021-11-15 2021-09-30 13F AMGEN COM 031162100 99,366 52,392 111.53 21,130 84.54 0.5211
2021-08-17 2021-06-30 13F AMGEN COM 031162100 46,974 32,906 233.91 11,450 227.42 0.4057
2021-05-18 2021-03-31 13F AMGEN COM 031162100 14,068 -1,188 -7.79 3,497 -0.23 0.2149
2021-02-12 2020-12-31 13F AMGEN COM 031162100 15,256 5,925 63.50 3,505 47.77 0.2398
2020-11-16 2020-09-30 13F AMGEN COM 031162100 9,331 -2,950 -24.02 2,372 -18.15 0.2293
2020-08-14 2020-06-30 13F AMGEN COM 031162100 12,281 6,800 124.06 2,898 160.85 0.2902
2020-05-15 2020-03-31 13F AMGEN COM 031162100 5,481 1,335 32.20 1,111 10.99 0.1770
2020-02-14 2019-12-31 13F AMGEN COM 031162100 4,146 4,146 1,001 0.3103
2019-11-14 2019-09-30 13F AMGEN COM 031162100 0 -3,866 -100.00 0 -100.00
2019-08-14 2019-06-30 13F AMGEN COM 031162100 3,866 26 0.68 713 -2.33 0.2602
2019-05-14 2019-03-31 13F AMGEN COM 031162100 3,840 -31 -0.80 730 -3.18 0.2739
2019-02-01 2018-12-31 13F AMGEN COM 031162100 3,871 3,871 754 0.4580
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.